Alimentación práctica del cerdo

The feed represent over 65% of production costs, so should be established as a priority. It is not enough that a diet meets the nutritional needs of pigs, the ration formulation must right with official regulations governing each country for the use and manufacture of feed. Also, the feed should be easy to preserve and supplying, taking into the wide variety to installations (feeders and drinkers) used in various stages of pigs. However, the fundamental objective of the formulation of a diet is that it contains the necessary nutrients in the correct proportions and balance, considering the physiological stage, weight, age, sex, genetic potential, health status, season and production objectives with a the legal constraints. Once accomplished the formulation, the next step will be insure preparing the feed under conditions that ensure the safety, traceability and lower cost of the same. To this challenge, is adding the need to the right with environmental regulations related to feed and animal welfare.La alimentación representan alrededor del 65% de los costes de producción, por ello debe establecerse como una prioridad. No es suficiente que una dieta cumpla con las necesidades nutricionales de los cerdos, la formulación debe obedecer las normativas oficiales que rigen en cada país para el uso y fabricación de alimentos. Asimismo, el alimento debe ser fácil de conservar y suministrar, asumiendo la gran variedad de instalaciones (comederos y bebederos) utilizadas en las distintas etapas de los cerdos. Sin embargo, el objetivo fundamental de la formulación de una dieta es que contenga los nutrientes necesarios en las cantidades correctas y equilibradas, considerando la etapa fisiológica, peso, edad, sexo, potencial genético, estado de salud, época del año, objetivos productivos y de producto final, así como las limitantes legales. Una vez cumplida la formulación, el siguiente paso es asegurar que ésta sea elaborada bajo condiciones que garanticen la inocuidad, trazabilidad y bajo costo de la misma. A este desafío, se añade la necesidad de cumplir con las normativas ambientales relacionadas con la alimentación y bienestar animal

Control of parameters of a porcine artificial insemination center

El uso de la inseminación artificial en España ha experimentado un gran crecimiento en estos últimos años. Conjuntamente ha crecido el número de centros de inseminación artificial (CIA) independientes o adosados a las explotaciones. Para rentabilizar al máximo dichos centros, se hace imprescindible una buena gestión, para el control de las condiciones ambientales donde se alojan los verracos, el estatus sanitario de los mismos, así como un seguimiento de la producción y calidad del semen. Con el fin de obtener dosis seminales con calidad y concentración adecuadas se pueden aplicar factores de corrección, en base a los diferentes parámetros espermáticos posibles de evaluar en un CIA, y así obtener un número adecuado de dosis inseminantes de cada verraco Así mismo, se hace necesario -realizar la programación del trabajo diario y maximizar la rentabilidad, controlando el ritmo de extracción de semen y optimizando el balance de dosis producidas, vendidas y desechadas. Cabe remarcar que la buena gestión de un CIA se facilita con el uso de programas informáticos.Artificial insemination has greatly developed in Spain in the past years. At the same time the number of artificial insemination centres (MC) has increased within the farms and independently. Good management is essential to render these centres profitable. Important factors are: environmental control, housing of the animals, health status and production and quality of semen. In order to get semen of high quality, correction factors based on the parameters which can be applied to semen evaluation in an AIC may be used. It is advisable tu establish a daily routine tu maximize rentability, control the collection rate and tu optimize the balance between semen obtained sold and wasted. Informatization of the AIC makes a good management easier.Facultad de Ciencias Veterinaria

Control of parameters of a porcine artificial insemination center

El uso de la inseminación artificial en España ha experimentado un gran crecimiento en estos últimos años. Conjuntamente ha crecido el número de centros de inseminación artificial (CIA) independientes o adosados a las explotaciones. Para rentabilizar al máximo dichos centros, se hace imprescindible una buena gestión, para el control de las condiciones ambientales donde se alojan los verracos, el estatus sanitario de los mismos, así como un seguimiento de la producción y calidad del semen. Con el fin de obtener dosis seminales con calidad y concentración adecuadas se pueden aplicar factores de corrección, en base a los diferentes parámetros espermáticos posibles de evaluar en un CIA, y así obtener un número adecuado de dosis inseminantes de cada verraco Así mismo, se hace necesario -realizar la programación del trabajo diario y maximizar la rentabilidad, controlando el ritmo de extracción de semen y optimizando el balance de dosis producidas, vendidas y desechadas. Cabe remarcar que la buena gestión de un CIA se facilita con el uso de programas informáticos.Artificial insemination has greatly developed in Spain in the past years. At the same time the number of artificial insemination centres (MC) has increased within the farms and independently. Good management is essential to render these centres profitable. Important factors are: environmental control, housing of the animals, health status and production and quality of semen. In order to get semen of high quality, correction factors based on the parameters which can be applied to semen evaluation in an AIC may be used. It is advisable tu establish a daily routine tu maximize rentability, control the collection rate and tu optimize the balance between semen obtained sold and wasted. Informatization of the AIC makes a good management easier.Facultad de Ciencias Veterinaria

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

The cause of Huntington disease (HD) is a polyglutamine repeat expansion of more than 36 units in the huntingtin protein, which is inversely correlated with the age at onset of the disease. However, additional genetic factors are believed to modify the course and the age at onset of HD. Recently, we identified the V471A polymorphism in the autophagy-related gene ATG7, a key component of the autophagy pathway that plays an important role in HD pathogenesis, to be associated with the age at onset in a large group of European Huntington disease patients. To confirm this association in a second independent patient cohort, we analysed the ATG7 V471A polymorphism in additional 1,464 European HD patients of the “REGISTRY” cohort from the European Huntington Disease Network (EHDN). In the entire REGISTRY cohort we could not confirm a modifying effect of the ATG7 V471A polymorphism. However, analysing a modifying effect of ATG7 in these REGISTRY patients and in patients of our previous HD cohort according to their ethnic origin, we identified a significant effect of the ATG7 V471A polymorphism on the HD age at onset only in the Italian population (327 patients). In these Italian patients, the polymorphism is associated with a 6-years earlier disease onset and thus seems to have an aggravating effect. We could specify the role of ATG7 as a genetic modifier for HD particularly in the Italian population. This result affirms the modifying influence of the autophagic pathway on the course of HD, but also suggests population-specific modifying mechanisms in HD pathogenesis

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Background Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis looking for Huntington's disease modifiers, but is hard to define and not always available. Therefore, we aimed to generate a novel measure of disease progression and to identify genetic markers associated with this progression measure. Methods We generated a progression score on the basis of principal component analysis of prospectively acquired longitudinal changes in motor, cognitive, and imaging measures in the 218 indivduals in the TRACK-HD cohort of Huntington's disease gene mutation carriers (data collected 2008–11). We generated a parallel progression score using data from 1773 previously genotyped participants from the European Huntington's Disease Network REGISTRY study of Huntington's disease mutation carriers (data collected 2003–13). We did a genome-wide association analyses in terms of progression for 216 TRACK-HD participants and 1773 REGISTRY participants, then a meta-analysis of these results was undertaken. Findings Longitudinal motor, cognitive, and imaging scores were correlated with each other in TRACK-HD participants, justifying use of a single, cross-domain measure of disease progression in both studies. The TRACK-HD and REGISTRY progression measures were correlated with each other (r=0·674), and with age at onset (TRACK-HD, r=0·315; REGISTRY, r=0·234). The meta-analysis of progression in TRACK-HD and REGISTRY gave a genome-wide significant signal (p=1·12 × 10−10) on chromosome 5 spanning three genes: MSH3, DHFR, and MTRNR2L2. The genes in this locus were associated with progression in TRACK-HD (MSH3 p=2·94 × 10−8 DHFR p=8·37 × 10−7 MTRNR2L2 p=2·15 × 10−9) and to a lesser extent in REGISTRY (MSH3 p=9·36 × 10−4 DHFR p=8·45 × 10−4 MTRNR2L2 p=1·20 × 10−3). The lead single nucleotide polymorphism (SNP) in TRACK-HD (rs557874766) was genome-wide significant in the meta-analysis (p=1·58 × 10−8), and encodes an aminoacid change (Pro67Ala) in MSH3. In TRACK-HD, each copy of the minor allele at this SNP was associated with a 0·4 units per year (95% CI 0·16–0·66) reduction in the rate of change of the Unified Huntington's Disease Rating Scale (UHDRS) Total Motor Score, and a reduction of 0·12 units per year (95% CI 0·06–0·18) in the rate of change of UHDRS Total Functional Capacity score. These associations remained significant after adjusting for age of onset. Interpretation The multidomain progression measure in TRACK-HD was associated with a functional variant that was genome-wide significant in our meta-analysis. The association in only 216 participants implies that the progression measure is a sensitive reflection of disease burden, that the effect size at this locus is large, or both. Knockout of Msh3 reduces somatic expansion in Huntington's disease mouse models, suggesting this mechanism as an area for future therapeutic investigation

Ram spermatozoa cocultured with epithelial cell monolayers An in vitro model for the study of capacitation and the acrosome reaction

The effects of different epithelial cells, namely, hamster oviduct, sheep oviduct, and pig kidney epithelial cells (IBRS‐2), on the viability, percentage of progressive motility (PPM), and acrosome reactions of ejaculated ram spermatozoa were investigated. Sperm aliquots were cultured on cells, cell‐conditioned medium 199, or control medium 199. The PPM of unattached spermatozoa was estimated after 0, 3, 6, 9, 12, and 24 hr of incubation at 37°C under 5% CO2 in air. Viability and the occurrence of true acrosome reactions were assessed using a triple‐stain technique. Spermatozoa started to attach within 1 hr of coculture with the hamster or sheep oviductal epithelial cell (OEC) monolayers, and these spermatozoa showed vigorous tail motion. No spermatozoa were found to attach to the IBRS‐2 monolayer. The PPM of unattached spermatozoa cocultured with the various types of epithelial cell monolayers for 12 hr was significantly higher than that of spermatozoa incubated in conditioned media or medium 199 alone (54% in hamster OEC vs. 40% in conditioned; 68% in sheep OEC vs. 38% in conditioned; 36% in control medium). On the other hand, after 24 hr of incubation, there were no differences in the PPM of spermatozoa cocultured with epithelial cells or incubated in conditioned media. The percentages of cells undergoing a true acrosome reaction reached maximum values (P < 0.05) in spermatozoa incubated for 9 hr in the presence of hamster OEC (22.5%) or for 12 hr on sheep OEC (20.5%) monolayers. IBRS‐2, a commercial nonreproductive cell type, had a positive influence on both PPM and sperm viability but no effect on the occurrence of the acrosome reaction. Interactions leading to the acrosome reaction were thus observed only when spermatozoa were cocultured with OEC monolayers. The values of PPM in unattached sperm cells seen after 12 hr of coculture with OEC or IBRS‐2 were still at a high level (52–67%) for in vitro fertilization. The coculture with OECs provides an “in vitro” model to study the capacitation processes in a situation that may resemble that occurring in vivo. Moreover, the coculture with hamster OECs may provide a convenient and standardized in vitro system to study mechanisms underlying capacitation and the acrosome reaction. © 1993 Wiley‐Liss, Inc. Copyright © 1993 Wiley‐Liss, Inc